Biolae

Biolae is an innovative, female-founded Australian life sciences and wellness brand dedicated to pioneering science-backed, evidence-based therapeutic solutions for women’s health. Recognising a significant gap in non-hormonal options for vulvovaginal health, Biolae bridges the divide between rigorous clinical validation and patient-centric care. At AOFOG 2026, Biolae is proud to mark a landmark milestone in Australian women’s health with the official launch of Fluvadin Plus, the first-ever TGA-listed medical device hyaluronic acid pessary (ovule) available in Australia. Developed specifically to address the pervasive challenges of vaginal dryness and Genitourinary Syndrome of Menopause (GSM), Biolae provides clinicians with a powerful, validated, hormone-free first-line therapy. Our mission is to empower practitioners across the Asia-Oceania region with innovative tools that improve patient compliance, restore tissue elasticity, and significantly elevate quality of life.